Tuesday , October 24 2017
Home / Resources / Clinical Presentations / GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4

See more GLP-1 Agonist Resources.

This week we wrap-up our four part series on GLP-1 Agonists. Topics covered this week include: "Treatment with Exenatide does not impair the counterregulatory glucagon response," "Incretin-related Anti-diabetes Drugs and effects on plasma glucagon," and "A new extra-islet target for GLP-1: The Heart"….

Link to download (.ppt format): Mechanisms of Action and Potential, Part 4 of 4

 

Other sets in this series:

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 2 of 4
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4